ACTIVE

Viatris Healthcare

Financial year 2025 · Closed on 31/12/2025

Net result1,4 M €-89,0 %over 1 year

Equity37,9 M €+3,9 %over 1 year

Identity

Source · BCE/KBO

Viatris Healthcare is a Public limited company incorporated in 1943. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Hoeilaart.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0403.048.064
Incorporation: 17/12/1943
Legal form: Public limited company
Registered office: Terhulpsesteenweg 6A
1560 Hoeilaart · FlandreSee on map
Contributed capital: 10 000 000,00 €
Latest accounts: 31/12/2025

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport 66199Other activities auxiliary to financial services, except insurance and pension funding 66199Other activities auxiliary to financial services, except insurance and pension funding

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 21 filings

Trend over 18 financial years

	2025		2024		2023		2022		2020
Income statement
Revenue	–		–		0 €	-100%	150 k €	-99.7%	58,3 M €
EBITDA	1,1 M €	-92.1%	13,9 M €	+572%	2,1 M €	-9.6%	2,3 M €	-58.7%	5,5 M €
Operating result	977,6 k €	-92.9%	13,8 M €	+613%	1,9 M €	-22.2%	2,5 M €	-13.2%	2,9 M €
Net result	1,4 M €	-89.0%	12,8 M €	+940%	1,2 M €	+381%	-438,9 k €	-118%	2,4 M €
Balance sheet
Equity	37,9 M €	+3.9%	36,5 M €	+54.0%	23,7 M €	+5.5%	22,5 M €	+8.6%	20,7 M €
Total assets	41,2 M €	+2.0%	40,5 M €	+45.4%	27,8 M €	-19.9%	34,7 M €	-0.9%	35 M €
Cash	–		–		–		–		–
Debts	3,3 M €	-15.7%	3,9 M €	-4.3%	4,1 M €	-66.5%	12,3 M €	-12.6%	14 M €
Other
Workforce	–		–		–		–		40,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 23 ended

Active mandates

Arun NARAYAN

Bestuurder · since 26 novembre 2025 · until 20 juin 2030

Active

Tomasz BUCZEK

Bestuurder · since 25 juin 2025 · until 20 juin 2030

Active

Ended mandates

Salzmann Matthew

Bestuurder · since 01 mars 2024 · until 28 juin 2029

Ended

Birbuet Luis

Bestuurder · since 16 mars 2021 · until 26 mai 2024

Ended

Luis Birbuet

Director · since 16 mars 2021 · until 26 mai 2024

Ended

VERSCHRAEGEN Vincent

Gedelegeerd bestuurder · since 18 décembre 2018 · until 26 mai 2024

Ended

Other companies at this address

Terhulpsesteenweg 6A 1560 Hoeilaart

Company	CBE no.
AKTUAPHARMA● Active	0463.582.004
Upjohn● Active	0552.558.025
Viatris GX● Active	0885.805.780
Viatris International Supply Point● Active	0463.648.419

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/07/2026	27/06/2025	27/06/2024	05/10/2023	11/10/2022	06/07/2021
General meeting	18/06/2026	19/06/2025	20/06/2024	05/10/2023	07/10/2022	17/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	18/06/2026	07/07/2026	Dutch	PDF
Full model	31/12/2024	19/06/2025	27/06/2025	Dutch	PDF
Full model	31/12/2023	20/06/2024	27/06/2024	Dutch	PDF
Full model	31/12/2022	05/10/2023	05/10/2023	Dutch	PDF
Full model	31/12/2021	07/10/2022	11/10/2022	Dutch	PDF
Full model	31/12/2020	17/06/2021	06/07/2021	Dutch	PDF
Full model	31/12/2019	18/06/2020	25/06/2020	Dutch	PDF
Full model	31/12/2018	20/06/2019	21/06/2019	Dutch	PDF
Full model	31/12/2017	31/08/2018	04/09/2018	French	PDF
Full model	31/12/2016	26/05/2017	09/06/2017	French	PDF
Full model	31/12/2015	26/05/2016	08/06/2016	French	PDF
Full model	31/12/2014	04/06/2015	04/06/2015	French	PDF
Full model	31/12/2013	22/05/2014	25/07/2014	French	PDF
Full model	31/12/2012	23/05/2013	03/06/2013	French	PDF
Full model	31/12/2011	24/05/2012	11/06/2012	French	PDF
Full model	31/12/2010	26/05/2011	27/05/2011	French	PDF
Full model	31/12/2009	27/05/2010	07/06/2010	French	PDF
Full model	31/12/2008	25/06/2009	25/06/2009	French	PDF
Full model	31/12/2007	22/05/2008	17/06/2008	French	PDF
Full modelCorrection	31/12/2006	24/05/2007	13/11/2007	French	PDF
Full model	31/12/2006	24/05/2007	07/06/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 23 ended

Active mandates

Arun NARAYAN

Bestuurder · since 26 novembre 2025 · until 20 juin 2030

Active

Tomasz BUCZEK

Bestuurder · since 25 juin 2025 · until 20 juin 2030

Active

Ended mandates

Salzmann Matthew

Bestuurder · since 01 mars 2024 · until 28 juin 2029

Ended

Birbuet Luis

Bestuurder · since 16 mars 2021 · until 26 mai 2024

Ended

Luis Birbuet

Director · since 16 mars 2021 · until 26 mai 2024

Ended

VERSCHRAEGEN Vincent

Gedelegeerd bestuurder · since 18 décembre 2018 · until 26 mai 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other02/07/2026
—
PDF
Mandates10/12/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates01/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/07/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/03/2024
ONTSLAGEN - BENOEMINGEN
PDF
Other25/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ALGEMENE VERGADERING
PDF
Other21/12/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 20251,4 M €↓
26/11/2025
nominationArun Narayan — bestuurder
25/06/2025
nominationTomasz Buczek — bestuurder
19/06/2025
reconductionDeloitte Bedrijfsrevisoren BV — commissaris
2024
Annual accounts 202412,8 M €↑
20/06/2024
reconductionVincent Verschraegen — gedelegeerd bestuurder
01/03/2024
nominationMatthew Salzmann — bestuurder
2023
Annual accounts 20231,2 M €↑
2022
Annual accounts 2022-438,9 k €↓
07/10/2022
reconductionDeloitte Bedrijfsrevisoren BV — commissaris
2022
Name changeViatris Healthcare NV
2020
Annual accounts 20202,4 M €↓
2019
Annual accounts 20194,1 M €↑
2018
Annual accounts 20183,7 M €↓
2017
Annual accounts 20177,3 M €↓
2016
Annual accounts 201613,4 M €↓
2015
Annual accounts 201528,6 M €↓
2014
Annual accounts 201432,5 M €↑
2012
Annual accounts 201230,5 M €↓
2011
Annual accounts 201132,6 M €↑
2010
Annual accounts 201015,3 M €↑
2009
Annual accounts 20094,3 M €↑
2008
Annual accounts 20083,9 M €↑
2007
Annual accounts 20072,6 M €↑
2006
Annual accounts 20062,5 M €
2006
Name changeMEDA PHARMA
17/12/1943
IncorporationPublic limited company

Viatris Healthcare

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline